Insider · CIK 0001337798
G Bradley Cole
Files at CSTL (CASTLE BIOSCIENCES INC), KNSA (Kiniksa Pharmaceuticals International, plc). First filing Mar 9, 2026, latest Mar 9, 2026.
G Bradley Cole files SEC Form 4 as director at CSTL (CASTLE BIOSCIENCES INC), and also at KNSA (Kiniksa Pharmaceuticals International, plc). Since Mar 9, 2026, G Bradley Cole has reported 0 open-market buys worth $0 and 1 open-market sell worth $211k, the latest filed on Mar 9, 2026.
A track record needs three past buys with six months of prices behind them; G Bradley Cole has 0, so none is measured yet.
The newest scored trade: sold $211k of CSTL on Mar 5, 2026, filed Mar 9, 2026, scored 37 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $211k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CSTL: CASTLE BIOSCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | CASTLE BIOSCIENCES INC | $211k 7,403 shares | -28% | +91% from low-35% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | 3,673 0.01% of outstanding | $299k | Jul 29, 2026 | none |
| Mar 5, 2026 | CSTL CASTLE BIOSCIENCES, INC. | 7,403 0.02% of outstanding | $211k | Mar 5, 2026 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,799 | - | - | 15,345 | Jun 2, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +12,158 | $0.00 | $0 | 12,158 | Jun 2, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitsderivative | +2,026 | $0.00 | $0 | 2,026 | Jun 2, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitsderivative | -2,799 | $0.00 | $0 | 0 | Jun 2, 2026 |
| May 28, 2026 | CSTL CASTLE BIOSCIENCES INC | AGrant or award Restricted Stock Unitsderivative | +11,766 | $0.00 | $0 | 11,766 | Jun 1, 2026 |
| May 22, 2026 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Common Stock | +13,667 | - | - | 32,976 | May 27, 2026 |
| May 22, 2026 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -13,667 | $0.00 | $0 | 0 | May 27, 2026 |
| Mar 5, 2026 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Common Stock | +4,748 | $3.38 | $16k | 26,712 | Mar 9, 2026 |
| Mar 5, 2026 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stock | -4,748 | $28.44 | $135k | 21,964 | Mar 9, 2026 |
| Mar 5, 2026 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stock | -2,655 | $28.51 | $76k | 19,309 | Mar 9, 2026 |
| Mar 5, 2026 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Stock option (right to buy)derivative | -4,748 | $0.00 | $0 | 20,000 | Mar 9, 2026 |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +3,173 | - | - | 12,546 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +16,798 | $0.00 | $0 | 16,798 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitsderivative | +2,799 | $0.00 | $0 | 2,799 | Jun 5, 2025 |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitsderivative | -3,173 | $0.00 | $0 | 0 | Jun 5, 2025 |
| May 21, 2025 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Common Stock | +8,673 | - | - | 21,964 | May 23, 2025 |
| May 21, 2025 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -8,673 | $0.00 | $0 | 0 | May 23, 2025 |
| May 22, 2025 | CSTL CASTLE BIOSCIENCES INC | AGrant or award Restricted Stock Unitsderivative | +13,667 | $0.00 | $0 | 13,667 | May 23, 2025 |
Questions about G Bradley Cole
Answered from the filings on this page, as of the latest one.
Is G Bradley Cole buying or selling?
In the last 12 months G Bradley Cole reported 0 open-market buys worth $0 and 1 open-market sell worth $211k on SEC Form 4; the latest was sold $211k of CSTL on Mar 5, 2026. Grants, option exercises and tax withholding are not counted.
How did G Bradley Cole's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and G Bradley Cole has 0.
Where does G Bradley Cole file Form 4?
G Bradley Cole has filed Form 4 at CSTL (CASTLE BIOSCIENCES INC); KNSA (Kiniksa Pharmaceuticals International, plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.